In particular, the study by Zhang et al. revealed that high sPD-L1 levels were linked to advanced disease stages, lymph node metastasis, and worse survival outcomes in HNSCC patients [47]. This evidence concerns the gene SPDL1 and metastatic malignant neoplasm in the lymph nodes.